RECRUITING

In Vivo Detection of Circulating Clots in Patients With Thromboembolism

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.

Official Title

In Vivo Detection of Circulating Clots in Patients With Thromboembolism

Quick Facts

Study Start:2023-07-26
Study Completion:2026-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05301348

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Sanjeeva Onteddu, MD
CONTACT
5016865135
sronteddu@uams.edu

Principal Investigator

Sanjeeva Onteddu, MD
PRINCIPAL_INVESTIGATOR
University of Arkansas
Jonathan A Young
STUDY_DIRECTOR
University of Arkansas

Study Locations (Sites)

Univerisity of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205
United States

Collaborators and Investigators

Sponsor: University of Arkansas

  • Sanjeeva Onteddu, MD, PRINCIPAL_INVESTIGATOR, University of Arkansas
  • Jonathan A Young, STUDY_DIRECTOR, University of Arkansas

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-26
Study Completion Date2026-01-31

Study Record Updates

Study Start Date2023-07-26
Study Completion Date2026-01-31

Terms related to this study

Additional Relevant MeSH Terms

  • Thromboembolism